Surat Institute of Digestive Sciences
Surat, Gujarat, India
Hospital in Surat, Gujarat
Gate 3, Ring Rd, opp. Gandhi College, Vijay Nagar, Majura Gate, Surat, Gujarat 395001
About Surat Institute of Digestive Sciences
"A 100 beded Gastro superspecility Hospital located in the centre of the Surat city. Its a centre for GI Medicine, GI Surgery, GI Endoscopy, GI Cancer treament. Facility equipped with 24 x 7 ICU back up , Dialysis Unit, OT, Endosuites, OPD, Lounges,Auditorium etc."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
5
Galapagos NV
4
Pfizer
4
Arena Pharmaceuticals
2
Gilead Sciences
2
Bayer
1
Fresenius Kabi
1
Takeda
1
Clinical Trials at Surat Institute of Digestive Sciences
During the past decade, Surat Institute of Digestive Sciences conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on
average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
2016-11-21
2025-07-30
Recruiting
600
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
2016-11-14
2020-03-31
Completed
1,351
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
2017-02-23
2026-09-01
Active, not recruiting
1,173
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
2017-03-17
2025-01-01
Enrolling by invitation
1,000
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
2016-11-01
2029-10-01
Recruiting
150
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
2017-07-11
2024-08-01
Active, not recruiting
139
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Surat Institute of Digestive Sciences" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Galapagos NV" with 4 trials
sponsored, "Pfizer" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Gilead Sciences"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Surat Institute of Digestive Sciences"
#1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Surat Institute of Digestive Sciences
According to Clinical.Site data, the most researched conditions in "Surat Institute of Digestive Sciences" are
"Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (2 trials), "Caloric Deficit" (1 trials) and "Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "Surat Institute of Digestive Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Surat Institute of Digestive Sciences
Most popular intervention types in "Surat Institute of Digestive Sciences" are "Drug" (19 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Filgotinib" (5 trials), "Etrasimod" (4 trials), "Guselkumab" (3 trials) and "Golimumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Surat Institute of Digestive Sciences
The vast majority of trials in "Surat Institute of Digestive Sciences" are
18 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Surat Institute of Digestive Sciences
Currently, there are NaN active trials in "Surat Institute of Digestive Sciences".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in Surat Institute of Digestive Sciences,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Surat Institute of Digestive Sciences, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".